(S (NP-SBJ The/DT candidate/NN oncoprotein/NN Bcl-3/NN) (VP is/VBZ (NP-PRD (NP an/DT antagonist/NN) (PP of/IN (NP (ADJP p50\/NF-kappa/NN B-mediated/JJ) inhibition/NN)))) ./.)
(S (NP-SBJ-18 The/DT candidate/NN oncogene/NN bcl-3/NN) (VP was/VBD (VP discovered/VBN (NP *-18/-NONE-) (PP as/IN (NP (NP a/DT translocation/NN) (PP into/IN (NP the/DT immunoglobulin/NN alpha-locus/NN)))) (PP in/IN (NP (NP some/DT cases/NNS) (PP of/IN (NP B-cell/NN chronic/JJ lymphocytic/JJ leukaemias/NNS)))))) ./.)
(S (NP-SBJ The/DT protein/NN Bcl-3/NN) (VP contains/VBZ (NP seven/CD so-called/JJ ankyrin/NN repeats/NNS)) ./.)
(S-COOD (S (NP-SBJ-19 Similar/JJ repeat/NN motifs/NNS) (VP are/VBP (VP found/VBN (NP *-19/-NONE-) (PP in/IN (NP (NP a/DT number/NN) (PP of/IN (NP diverse/JJ regulatory/JJ proteins/NNS))))))) but/CC (S (NP-SBJ (NP the/DT motifs/NNS) (PP of/IN (NP Bcl-3/NN))) (VP are/VBP (ADJP-PRD (ADVP most/RBS closely/RB) related/JJ (PP to/TO (NP (NP those/DT) (VP found/VBN (NP */-NONE-) (PP in/IN (NP (NP I/NN kappa/NN B/NN proteins/NNS) (SBAR (WHPP-21 in/IN (WHNP which/WDT)) (S (NP-SBJ-22 the/DT ankyrin/NN repeat/NN domain/NN) (VP is/VBZ (VP thought/VBN (S (NP-SBJ-23 *-22/-NONE-) (VP to/TO (VP be/VB (ADVP directly/RB) (VP involved/VBN (NP *-23/-NONE-) (PP in/IN (NP (NP inhibition/NN) (PP of/IN (NP NF-kappa/NN B/NN activity/NN)))) (PP *T*-21/-NONE-))))))))))))))))) ./.)
(S-COOD (S (NP-SBJ-24 No/DT biological/JJ function/NN) (VP has/VBZ (ADVP yet/RB) (VP been/VBN (VP described/VBN (NP *-24/-NONE-) (PP for/IN (NP Bcl-3/NN)))))) ,/, but/CC (S (NP-SBJ it/PRP) (VP was/VBD (VP noted/VBN (ADVP-TMP recently/RB) (SBAR that/IN (S (NP-SBJ Bcl-3/NN) (VP interferes/VBZ (PP with/IN (NP (NP DNA-binding/NN) (PP of/IN (NP (NP the/DT p50/NN subunit/NN) (PP of/IN (NP NF-kappa/NN B/NN)))))) (ADVP in/FW vitro/FW))))))) ./.)
(S (ADVP Here/RB) (NP-SBJ we/PRP) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ-25 Bcl-3/NN) (VP can/MD (VP aid/VB (NP (ADJP kappa/NN B/NN site-dependent/JJ) transcription/NN) (ADVP in/FW vivo/FW) (PP by/IN (S (NP-SBJ *-25/-NONE-) (VP counteracting/VBG (NP (NP the/DT inhibitory/JJ effects/NNS) (PP of/IN (NP p50\/NF-kappa/NN B/NN homodimers/NNS))))))))))) ./.)
(S (NP-SBJ Bcl-3/NN) (VP may/MD (ADVP therefore/RB) (VP aid/VB (NP (NP activation/NN) (PP of/IN (NP (NP select/JJ (ADJP NF-kappa/NN B-regulated/JJ) genes/NNS) ,/, (PP including/VBG (NP (NP those/DT) (PP of/IN (NP the/DT human/JJ immunodeficiency/NN virus/NN))))))))) ./.)
